Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Alopecia - R-Tech Ueno Starts Early Phase II Clinical Trial for RK-023
Biopharmaceuticals - Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
Bristol-Myers Squibb Company and AstraZeneca - Study Finds That ONGLYZA saxagliptin When Added to Metformin was Non-Inferior to JANUVIA sitagliptin When Added to Metformin in Reducing Hemoglobin HbA1c in Adults With Type 2 Diabetes Mellitus
Lung Cancer - Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial
Obesity - Data on VIVUS' Qnexa To Be Featured at the Obesity Society Annual Meeting
Type 2 Diabetes - Study Finds That ONGLYZA(TM) (saxagliptin) When Added to Metformin was Non-Inferior to JANUVIA (sitagliptin) When Added to Metformin in Reducing Hemoglobin (HbA1c RIGHTPARE
Adenocarcinoma - Data on adenocarcinoma reported by J. Cadranel and co-researchers
Adverse Drug Reactions - New adverse drug reactions data have been reported by J. Weber and co-authors
Cancer - Recent findings from University of California highlight research in cancer
Colon Cancer - Researchers from University of Connecticut publish new studies and findings in the area of colon cancer
Heart Attack - Studies from J.H. Traverse and co-researchers yield new data on heart attack
Immunization - New immunization research from I. Honma and co-researchers described
Lymphoma - Researchers from Columbia University provide details of new studies and findings in the area of lymphoma
Neutropenia - New findings from D. Binder and co-authors describe advances in neutropenia
Non-Small Cell Lung Cancer - New findings from University of Texas in the area of non-small cell lung cancer described
Non-Small Cell Lung Cancer - Reports from University of Toronto add new data to research in non-small cell lung cancer
Non-Small Cell Lung Cancer - Studies from M. Zwitter and co-researchers update current data on non-small cell lung cancer
Oncology - Northwestern University details research in oncology
Pharmacokinetics - New pharmacokinetics research from J.V. Scanlon and co-researchers described
Stem Cell Research - Studies conducted at K.C. Straathof et al on stem cell research recently published
Vaccines - Studies from Medical University of Vienna in the area of vaccines published
Cancer Therapy - Research from University of California in cancer therapy provides new insights
Colon Cancer Therapy - Studies from University Hospital describe new findings in colon cancer therapy
Esophageal Cancer Therapy - Study findings from National Cancer Center provide new insights into esophageal cancer therapy
Squamous Cell Carcinoma Therapy - Scientists at National Cancer Center Hospital East publish new data on squamous cell carcinoma therapy
Antifungals - TOPICA Announces Positive Phase 2 Clinical Results for Luliconazole, a Potent Topical Antifungal
ArQule, Inc. - ArQule Provides Clinical Update on ARQ 197
ArQule, Inc. - CORRECTING and REPLACING ArQule Provides Clinical Update on ARQ 197
BioDelivery Sciences International, Inc. - BioDelivery Sciences Receives $1.3 Million US Army Grant for Investigation of Bioral Amphotericin B in Topical Leishmaniasis
Bristol-Myers Squibb Company - Dapagliflozin Study Demonstrated Significantly Improved Glycemic Control and Weight Reduction in Type 2 Diabetes Patients Inadequately Controlled with Metformin
Cancer - Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
Chronic Lymphocytic Leukemia - Phase 2 Study of KRX-0401 (Perifosine) in Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma Open for Enrollment at Duke Comprehensive Cancer Center
Depomed, Inc. - Depomed, Inc. Announces Positive Top-Line Results from Phase 3 Clinical Trial of DM-1796 in Postherpetic Neuralgia
Drug Development - Sequella Receives American Recovery and Reinvestment Funding Through the NIH
Gaucher Disease - Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease
Genzyme Corporation - Genzyme Receives FDA Complete Response Letter for Clolar
Hepatitis C Virus - Conatus Pharmaceuticals to Present at the Montgomery Healthcare Conference
Kendle International Inc. - Kendle Appoints John Needham Executive Director and Global Head, Patient Enrollment Strategy
Lantheus Medical Imaging, Inc. - Data Featuring Gadofosveset Trisodium, the First and Only MRA Blood Pool Agent Approved in the U.S., Presented At MRA-Club 09: the 21st Annual International Conference on Magnetic Resonance Angiography
Menstruation - Vantia Therapeutics' VA111913 Enters Phase II Proof-of-Concept Trials for Dysmenorrhoea Phase I Results Show VA111913 to be Safe and Well Tolerated
Mystic Pharmaceuticals, Inc. - MacuCLEAR and Mystic Successfully Complete Phase Ib Clinical Trial for Macular Degeneration
Omeros Corporation - Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
Pharmaceuticals - Transdel Pharmaceuticals Announces Positive Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R)
Pico-Tesla Magnetic Therapies, Inc. - Pico-Tesla Starts Phase III Clinical Trial of Its Proprietary Magnetic Magneceutical(TM) Therapy for Parkinson's Disease
Pneumonia - Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and IV Antibiotic in Phase 3
Prostate Cancer - OncoGenex Pharmaceuticals CEO Named Canada's Pacific Ernst & Young's Entrepreneur of the Year(R) in the Health Sciences Category
RegeneRx Biopharmaceuticals, Inc. - Promising Clinical Data with RegeneRx's Tb4 Drug Candidates Presented on Second Day of Thymosin Meeting
Relypsa, Inc. - Relypsa Initiates Phase 2b Clinical Trial of RLY5016 for the Prevention of Hyperkalemia in Heart Failure Patients
Seattle Genetics, Inc. - Seattle Genetics Announces Discontinuation of Dacetuzumab Phase IIb Diffuse Large B-Cell Lymphoma Clinical Trial
